6/26/2025

ISELIN, N.J., June 26, 2025--Ephicacy Consulting Group, Inc. has announced the addition of Névine Zariffa to the board.

Source: Yahoo

6/25/2025

Health care stocks were rising late Wednesday afternoon, with the NYSE Health Care Index and the Hea

Source: Yahoo

6/25/2025

Health care stocks were decreasing Wednesday afternoon, with the NYSE Health Care Index down 0.3% an

Source: Yahoo

6/25/2025

LONDON (Reuters) -Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving its current cost, they said on Wednesday. The vaccine, Mosquirix or RTS,S, was developed by GSK and the non-profit PATH, and was the first malaria vaccine to get approval from the World Health Organization in 2022. GSK is working on a technology transfer to Bharat, and will continue to supply the adjuvant part of the vaccine to Bharat when the Indian drugmaker fully takes over production of the shot by 2028.

Source: Yahoo

6/24/2025

GSK's marketing application for linerixibat, targeting cholestatic pruritus in PBC patients, gains EMA acceptance based on phase III success.

Source: Yahoo

6/24/2025

PHILADELPHIA, June 24, 2025--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a 200 mg/mL autoinjector of Benlysta (belimumab), a B-lymphocyte stimulator (BlyS)-specific inhibiting monoclonal antibody, for subcutaneous injection in patients five years of age and older with active lupus nephritis (LN) who are receiving standard therapy. With this approval, GSK is expanding choices for belimumab treatment, offering pediatric lupus nephritis patien

Source: Yahoo

6/23/2025

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Source: Yahoo

6/23/2025

Discover why Genmab A/S stands out as a high-margin biotech with strong partnerships, robust growth prospects, and undervalued metrics. Click for more on GMAB.

Source: SeekingAlpha

6/19/2025

GILD wins FDA approval for Yeztugo, the first and only twice-yearly injectable PrEP for HIV prevention in the United States.

Source: Yahoo

6/18/2025

GSK stock is up 21.5% in six months, fueled by strong Specialty Medicines growth and a promising pipeline despite vaccine headwinds.

Source: Yahoo

6/17/2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Source: Yahoo

6/17/2025

GSK plc (NYSE:GSK) is one of the 12 best healthcare stocks to buy now. On June 12, the company announced licensing its Shigella vaccine candidate to Bharat Biotech. The licensing is part of the company’s effort to get the vaccine to patients where the pathogen poses a significant threat of causing death from diarrhea. Shigella […]

Source: Yahoo

6/16/2025

PHILADELPHIA, June 16, 2025--GSK plc (LSE/NYSE: GSK) today announced the launch of the Linked by Lupus: Optimal Care Initiative to help support individuals impacted with lupus, particularly systemic lupus erythematosus (SLE) and lupus nephritis (LN).

Source: Yahoo

6/14/2025

Amgen beat Q1 estimates with strong margins driven by Blincyto, Prolia, and standout Imdelltra growth, plus strength in obesity. See why AMGN stock is a buy.

Source: SeekingAlpha

6/13/2025

Recently, GSK (LSE:GSK) announced that the European Medicines Agency accepted its regulatory application to expand the use of its RSV vaccine, Arexvy, to adults aged 18 and older. This announcement likely supported the company's 14% share price increase last month, alongside positive movements such as the FDA's review of linerixibat and early success in Tebipenem HBr trials. These advancements contrast the broader market, which experienced turbulence amid geopolitical tensions and surging oil...

Source: Yahoo

6/11/2025

Tebipenem's approval in 2026 under SPA could bring Spero $400M+ in milestones & royalties. Read more on why SPRO is a Buy, given acquisition interest and other upside potential.

Source: SeekingAlpha

6/11/2025

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: VACCINE ADVISORY COMMITTEE: In an opinion article published by The Wall Street Journal, Robert F. Kennedy Jr. stated, “Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agenci

Source: Yahoo

6/9/2025

Vaccines stocks were mixed Tuesday after HHS fired all members of a CDC committee in charge of making vaccine suggestions.

Source: Yahoo

6/10/2025

Major vaccine policy changes could be on the horizon as the HHS removes key advisors. Click for my thoughts on what this may mean for the industry.

Source: SeekingAlpha

6/9/2025

Vaccines stocks slipped late Monday after HHS fired all members of a CDC committee in charge of making vaccine suggestions.

Source: Yahoo